Literature DB >> 17026631

Science communication in transition: genomics hype, public engagement, education and commercialization pressures.

T Bubela1.   

Abstract

This essay reports on the final session of a 2-day workshop entitled 'Genetic Diversity and Science Communication', hosted by the CIHR Institute of Genetics in Toronto, April 2006. The first speaker, Timothy Caulfield, introduced the intersecting communities that promulgate a 'cycle of hype' of the timelines and expected outcomes of the Human Genome Project (HGP): scientists, the media and the public. Other actors also contribute to the overall hype, the social science and humanities communities, industry and politicians. There currently appears to be an abatement of the overblown rhetoric of the HGP. As pointed out by the second speaker, Sharon Kardia, there is broad recognition that most phenotypic traits, including disease susceptibility are multi-factorial. That said, George Davey-Smith reminded us that some direct genotype-phenotype associations may be useful for public health issues. The Mendelian randomization approach hopes to revitalize the discipline of epidemiology by strengthening causal influences about environmentally modifiable risk factors. A more realistic informational environment paves the way for greater public engagement in science policy. Two such initiatives were presented by Kardia and Jason Robert, and Peter Finegold emphasized that science education and professional development for science teachers are important components of later public engagement in science issues. However, pressures on public research institutions to commercialize and seek industry funding may have negative impacts in both encouraging scientists to inappropriately hype research and on diminishing public trust in the scientific enterprise. The latter may have a significant effect on public engagement processes, such as those proposed by Robert and Kardia.

Entities:  

Mesh:

Year:  2006        PMID: 17026631     DOI: 10.1111/j.1399-0004.2006.00693.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Science communication reconsidered.

Authors:  Tania Bubela; Matthew C Nisbet; Rick Borchelt; Fern Brunger; Cristine Critchley; Edna Einsiedel; Gail Geller; Anil Gupta; Jürgen Hampel; Robyn Hyde-Lay; Eric W Jandciu; S Ashley Jones; Pam Kolopack; Summer Lane; Tim Lougheed; Brigitte Nerlich; Ubaka Ogbogu; Kathleen O'Riordan; Colin Ouellette; Mike Spear; Stephen Strauss; Thushaanthini Thavaratnam; Lisa Willemse; Timothy Caulfield
Journal:  Nat Biotechnol       Date:  2009-06       Impact factor: 54.908

Review 2.  The role of expectations, hype and ethics in neuroimaging and neuromodulation futures.

Authors:  Elena Rusconi; Timothy Mitchener-Nissen
Journal:  Front Syst Neurosci       Date:  2014-10-31

3.  Pharmacogenetics and the print media: what is the public told?

Authors:  Basima Almomani; Ahmed F Hawwa; Nicola A Goodfellow; Jeffrey S Millership; James C McElnay
Journal:  BMC Med Genet       Date:  2015-05-09       Impact factor: 2.103

4.  Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefit.

Authors:  Isabelle Boutron; Romana Haneef; Amélie Yavchitz; Gabriel Baron; John Novack; Ivan Oransky; Gary Schwitzer; Philippe Ravaud
Journal:  BMC Med       Date:  2019-06-04       Impact factor: 8.775

5.  Technology assessment and resource allocation for predictive genetic testing: a study of the perspectives of Canadian genetic health care providers.

Authors:  Alethea Adair; Robyn Hyde-Lay; Edna Einsiedel; Timothy Caulfield
Journal:  BMC Med Ethics       Date:  2009-06-18       Impact factor: 2.652

6.  Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals.

Authors:  Tania Bubela; Heather Boon; Timothy Caulfield
Journal:  BMC Med       Date:  2008-11-26       Impact factor: 8.775

Review 7.  At the cross-roads of participatory research and biomarker discovery in autism: the need for empirical data.

Authors:  Afiqah Yusuf; Mayada Elsabbagh
Journal:  BMC Med Ethics       Date:  2015-12-15       Impact factor: 2.652

Review 8.  Genomic medicine and developing countries: creating a room of their own.

Authors:  Béatrice Séguin; Billie-Jo Hardy; Peter A Singer; Abdallah S Daar
Journal:  Nat Rev Genet       Date:  2008-06       Impact factor: 53.242

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.